Cbzymes India Profile
Key Indicators
- Authorised Capital ₹ 1.10 Cr
as on 29-07-2024
- Paid Up Capital ₹ 1.10 Cr
as on 29-07-2024
- Company Age 7 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 Cr
as on 29-07-2024
- Revenue 71.83%
(FY 2023)
- Profit 106.43%
(FY 2023)
- Ebitda 81.88%
(FY 2023)
- Net Worth 95.06%
(FY 2023)
- Total Assets 88.56%
(FY 2023)
About Cbzymes India
The Corporate was formerly known as Rinder Agrotech Private Limited. The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.10 Cr and a paid-up capital of Rs 1.10 Cr.
The company currently has active open charges totaling ₹1.00 Cr.
Shailesh Choubey, Mithlesh Choubey, and Manish Choubey serve as directors at the Company.
- CIN/LLPIN
U74999BR2017PTC034131
- Company No.
034131
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Mar 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Company Details
- Location
Rohtas, Bihar, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Cbzymes India?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mithlesh Choubey  | Director | 28-Mar-2017 | Current |
| Shailesh Choubey | Director | 28-Mar-2017 | Current |
| Manish Choubey | Director | 04-Sep-2023 | Current |
Financial Performance of Cbzymes India.
Cbzymes India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 71.83% increase. The company also saw a substantial improvement in profitability, with a 106.43% increase in profit. The company's net worth Soared by an impressive increase of 95.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cbzymes India?
In 2023, Cbzymes India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Cb Agro Food Private LimitedActive 5 years 6 monthsShailesh Choubey, Mithlesh Choubey and 1 more are mutual person
- Cb Biofuels Private LimitedActive 2 years 11 months
Shailesh Choubey, Mithlesh Choubey and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 30 Jan 2023 | ₹1.00 Cr | Open |
How Many Employees Work at Cbzymes India?
Cbzymes India has a workforce of 0 employees as of Mar 20, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cbzymes India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cbzymes India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
